Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Kerstin N. Timm, Damian J. Tyler
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 2, pp. 255-269
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Pushkar Singh Rawat, Aiswarya Jaiswal, Amit Khurana, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111708-111708
Open Access | Times Cited: 537
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
Vincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 264
Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner
Wei Yu, Xing Qin, Yuchen Zhang, et al.
Cardiovascular Diagnosis and Therapy (2020) Vol. 10, Iss. 4, pp. 752-769
Open Access | Times Cited: 141
Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
Mohammad Sheibani, Yaser Azizi, Maryam Shayan, et al.
Cardiovascular Toxicology (2022) Vol. 22, Iss. 4, pp. 292-310
Closed Access | Times Cited: 132
Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway
Hang Chen, Ji Zhu, Yifei Le, et al.
Phytomedicine (2022) Vol. 99, pp. 153964-153964
Closed Access | Times Cited: 81
Exercise training maintains cardiovascular health: signaling pathways involved and potential therapeutics
Huihua Chen, Chen Chen, Michail Spanos, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 81
The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
Rony Abdi Syahputra, Urip Harahap, Aminah Dalimunthe, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 80
AMPK and NRF2: Interactive players in the same team for cellular homeostasis?
Eleni Petsouki, Shara Natalia Sosa Cabrera, Elke H. Heiß
Free Radical Biology and Medicine (2022) Vol. 190, pp. 75-93
Open Access | Times Cited: 67
Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents
Mohammad Amin Manavi, Mohammad Hosein Fathian Nasab, Razieh Mohammad Jafari, et al.
Journal of Chemotherapy (2024) Vol. 36, Iss. 8, pp. 623-653
Closed Access | Times Cited: 16
The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors
Mohamed S. Dabour, Mina Y. George, Mary R. Daniel, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 159-182
Open Access | Times Cited: 15
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
Valentina Rausch, Valentina Sala, Fabio Penna, et al.
Oncogenesis (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 96
AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging
Antero Salminen, Anu Kauppinen, Kai Kaarniranta
Journal of Molecular Medicine (2019) Vol. 97, Iss. 8, pp. 1049-1064
Open Access | Times Cited: 92
AMP-activated protein kinase: A remarkable contributor to preserve a healthy heart against ROS injury
Alice Marino, Derek J. Hausenloy, Ioanna Andreadou, et al.
Free Radical Biology and Medicine (2021) Vol. 166, pp. 238-254
Open Access | Times Cited: 85
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1834-1834
Open Access | Times Cited: 73
Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy
Ye Chen‐Izu, Saixian Shi, Yan Dai
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113903-113903
Open Access | Times Cited: 62
Toxic effects and molecular mechanism of doxorubicin on different organs – an update
Kaviyarasi Renu, Lakshmi Prasanna Pureti, Balachandar Vellingiri, et al.
Toxin Reviews (2021) Vol. 41, Iss. 2, pp. 650-674
Closed Access | Times Cited: 55
Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
Xiaopeng Zhao, Zheng Tian, Mingli Sun, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets
Bing Jiang, Xuan Zhou, Tao Yang, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 33
Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account
Roberta Vitale, Stefania Marzocco, Ada Popolo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7477-7477
Open Access | Times Cited: 10
Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control
Anabel Díaz-Guerra, Rocío Villena-Gutiérrez, Agustín Clemente‐Moragón, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 217-232
Open Access | Times Cited: 8
Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity
Hanne M. Boen, Martina Cherubin, Constantijn Franssen, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 183-199
Open Access | Times Cited: 7
Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity
Ling He, Fuxiang Liu, Juxiang Li
Cardiovascular Toxicology (2021) Vol. 21, Iss. 3, pp. 179-191
Closed Access | Times Cited: 47
SIRT4 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the AKT/mTOR/Autophagy Pathway
Ling He, Jihong Wang, Yuting Yang, et al.
Toxicology (2022) Vol. 469, pp. 153119-153119
Closed Access | Times Cited: 35
Nuanxinkang prevents the development of myocardial infarction-induced chronic heart failure by promoting PINK1/Parkin-mediated mitophagy
Zhuoji Guan, Jie Chen, Linhai Wang, et al.
Phytomedicine (2022) Vol. 108, pp. 154494-154494
Closed Access | Times Cited: 28
Empagliflozin attenuates doxorubicin-induced cardiotoxicity by activating AMPK/SIRT-1/PGC-1α-mediated mitochondrial biogenesis
Meicong Chen
Toxicology Research (2023) Vol. 12, Iss. 2, pp. 216-223
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top